By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The National Institute of Neurological Disorders and Stroke has launched a new program that aims to spur development of biomarkers for use in battling Parkinson's disease and plans to use $5 million this year to fund such projects.

In addition to developing new biomarkers, the $5 million this year will go toward the development of new discovery tools and testing them.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.